CNT

CNT is a South Korean biotechnology company focused on the development of innovative therapeutic solutions for ophthalmic and metabolic diseases. The company primarily leverages the properties of Ciliary Neurotrophic Factor (CNTF) to address degenerative conditions of the eye, such as retinitis pigmentosa and age-related macular degeneration. Their approach often involves advanced delivery systems, including encapsulated cell therapy, to provide sustained release of neuroprotective agents. Beyond ophthalmology, CNT explores metabolic applications for its protein-based therapies, targeting conditions like obesity. The company aims to bridge the gap between laboratory research and clinical application through strategic partnerships and rigorous clinical trials.